Xintela AB Total Liabilities

Latest as of September 2025: Skr36.95 Million SEK ≈ $3.98 Million USD

Xintela AB total liabilities. Based on the latest financial reports, Xintela AB (XINT) has total liabilities worth Skr36.95 Million SEK (≈ $3.98 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check XINT financial resilience to evaluate the company's liquid asset resilience ratio.

Total Liabilities of Xintela AB (2013–2024)

Total liabilities of Xintela AB from 2013 to 2024. This chart illustrates how Xintela AB's total liabilities have evolved over time, based on quarterly financial data.

Xintela AB Competitors by Total Liabilities

The table below lists competitors of Xintela AB ranked by their total liabilities.

Company	Country	Total Liabilities
BSL Corp Bhd KLSE:7221	Malaysia	RM83.06 Million
TAG Oil Ltd. V:TAO	Canada	CA$2.43 Million
i2S SA PA:ALI2S	France	€6.67 Million
Tvardi Therapeutics, Inc. NASDAQ:TVRD	USA	$9.13 Million
Adventa Bhd KLSE:7191	Malaysia	RM21.83 Million
Volt Power Group Ltd AU:VPR	Australia	AU$1.81 Million
G Capital Bhd KLSE:7676	Malaysia	RM66.75 Million
Proteomics International Laboratories Ltd AU:PIQ	Australia	AU$4.09 Million

Liability Composition Analysis (2013–2024)

This chart breaks down Xintela AB's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Xintela AB (XINT) total assets.

Liquidity & Leverage Metrics

Xintela AB Total Liabilities Ratios Explained

Xintela AB total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	0.23	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	0.09	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	-1.33	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	4.07	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Xintela AB's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Xintela AB (2013–2024)

The table below shows the annual total liabilities of Xintela AB from 2013 to 2024.

Year	Total Liabilities	Change
2024-12-31	Skr30.75 Million ≈ $3.31 Million	+119.39%
2023-12-31	Skr14.02 Million ≈ $1.51 Million	-25.21%
2022-12-31	Skr18.74 Million ≈ $2.02 Million	-9.88%
2021-12-31	Skr20.80 Million ≈ $2.24 Million	-0.53%
2020-12-31	Skr20.91 Million ≈ $2.25 Million	+169.10%
2019-12-31	Skr7.77 Million ≈ $836.07K	+62.91%
2018-12-31	Skr4.77 Million ≈ $513.22K	-53.11%
2017-12-31	Skr10.17 Million ≈ $1.09 Million	+254.85%
2016-12-31	Skr2.87 Million ≈ $308.43K	-9.33%
2015-12-31	Skr3.16 Million ≈ $340.17K	+231.24%
2014-12-31	Skr954.29K ≈ $102.70K	-52.34%
2013-12-31	Skr2.00 Million ≈ $215.50K	--

About Xintela AB

ST:XINT Sweden Biotechnology

Market Cap

$11.13 Million

Skr103.39 Million SEK

Market Cap Rank

#26642 Global

#561 in Sweden

Share Price

Skr0.15

Change (1 day)

-5.16%

52-Week Range

Skr0.15 - Skr0.39

All Time High

Skr8.60